Last $0.37 USD
Change Today +0.02 / 5.71%
Volume 324.9K
As of 8:10 PM 10/17/14 All times are local (Market data is delayed by at least 15 minutes).

cocrystal pharma inc (COCP) Snapshot

Open
$0.35
Previous Close
$0.35
Day High
$0.37
Day Low
$0.35
52 Week High
10/21/13 - $0.88
52 Week Low
11/13/13 - $0.23
Market Cap
45.1M
Average Volume 10 Days
224.9K
EPS TTM
--
Shares Outstanding
122.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for COCRYSTAL PHARMA INC (COCP)

Related News

No related news articles were found.

cocrystal pharma inc (COCP) Related Businessweek News

No Related Businessweek News Found

cocrystal pharma inc (COCP) Details

Cocrystal Pharma, Inc., a preclinical-stage biopharmaceutical company, intends to develop medicines for use in treating human viral diseases. The company focuses on developing inhibitors of viral replication enzymes that are essential to viral replication. It is developing antiviral therapeutics for human diseases, including Hepatitis C virus, Influenza virus, Rhinovirus, Dengue Virus, and Norovirus. The company also develops targeted in-house chemical libraries consisting of antiviral compounds of various types, including non-nucleoside inhibitors, metal-binding inhibitors, and fragments. In addition, it is developing compounds that inhibit HCV helicase, an enzyme that is essential for hepatitis C viral replication. The company was founded in 2007 and is headquartered in Bothell, Washington.

cocrystal pharma inc (COCP) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

cocrystal pharma inc (COCP) Key Developments

Cocrystal Pharma, Inc. Replaces Paritz & Company P.A. with BDO USA, LLP as Independent Registered Public Accounting Firm

On April 22, 2014, Cocrystal Pharma, Inc. dismissed Paritz & Company, P.A. as the company’s independent registered public accounting firm. The decision to dismiss the former auditor was approved by the company’s audit committee. On April 18, 2014, BDO USA, LLP was appointed to serve as the company’s new independent registered public accounting firm. The engagement of BDO as the company’s new independent registered public accounting firm was approved by the company’s audit committee.

Cocrystal Pharma, Inc. has Changed its Ticker to COCP from BZNE

Effective April 15, 2014, Cocrystal Pharma, Inc. changed its OTC Bulletin Board stock ticker symbol to COCP from BZNE.

Biozone Pharmaceuticals, Inc. has Changed its Ticker to COCP from BZNE

Effective April 15, 2014, Biozone Pharmaceuticals, Inc. changed its OTC Bulletin Board stock ticker symbol to COCP from BZNE.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
COCP:US $0.37 USD +0.02

COCP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for COCP.
View Industry Companies
 

Industry Analysis

COCP

Industry Average

Valuation COCP Industry Range
Price/Earnings 17.6x
Price/Sales -- Not Meaningful
Price/Book 7.4x
Price/Cash Flow 17.6x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COCRYSTAL PHARMA INC, please visit www.cocrystalpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.